The long-term goal of this research is a better understanding of what factors determine the addictive liabilities of drugs. Using prototypical agents, experiments are planned to analyze further the neuropsychological mechanisms of opiate (e.g., morphine, meperidine), stimulant (e.g., d-amphetamine, cocaine), and hallucinogen (e.g., phencyclidine, LSD) addiction in rats. A major focus will be the determination of neuroanatomical site(s) of drug action(s) with particular reference to differential involvement of the two sides of the brain. Specific experimental problems will include the following: (1) The effects of drugs on electrical self-stimulation of the brain will continue to be studied and characterized in terms of their differential actions in the two sides of the brain. Ongoing studies with lateral hypothalamic and hippocampal placements will be completed, and striatum and frontal cortex will be studied next. (2) Mechanisms that differentiate cocaine from d-amphetamine will be investigated with respect to the hypothesis that cocaine selectively activates dopaminergic mesocortical pathways that can also be activated by stress. (3) The mechanism of asymmetry in the dopaminergic nigrostriatal system will be investigated with respect to the hypothesis that there are dual excitatory and inhibitory inputs and that rats can be distinguished on the basis of which input predominates. (4) Individual differences in brain lateralization that underlie behavioral differences in sensitivity to opiates, stimulants, and hallucinogens will be investigated. Left-, right- and non-sided rats of both sexes will be compared for their responsiveness to behavioral effects (e.g., drug self-administration, locomotor activity) of these drugs. If possible, similar comparisons will be made between rats distinguished as in (3) above. These studies should provide an animal model for understanding different drug preferences and patterns of abuse among humans.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA003817-04
Application #
3208522
Study Section
(DABA)
Project Start
1984-07-01
Project End
1989-03-31
Budget Start
1987-04-01
Budget End
1988-03-31
Support Year
4
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Albany Medical College
Department
Type
Schools of Medicine
DUNS #
City
Albany
State
NY
Country
United States
Zip Code
12208
Shoblock, James R; Maisonneuve, Isabelle M; Glick, Stanley D (2004) Differential interactions of desipramine with amphetamine and methamphetamine: evidence that amphetamine releases dopamine from noradrenergic neurons in the medial prefrontal cortex. Neurochem Res 29:1437-42
Pace, Christopher J; Glick, Stanley D; Maisonneuve, Isabelle M et al. (2004) Novel iboga alkaloid congeners block nicotinic receptors and reduce drug self-administration. Eur J Pharmacol 492:159-67
Shoblock, James R; Maisonneuve, Isabelle M; Glick, Stanley D (2003) Differences between d-methamphetamine and d-amphetamine in rats: working memory, tolerance, and extinction. Psychopharmacology (Berl) 170:150-6
Zhang, Wenjiang; Ramamoorthy, Yamini; Tyndale, Rachel F et al. (2003) Interaction of buprenorphine and its metabolite norbuprenorphine with cytochromes p450 in vitro. Drug Metab Dispos 31:768-72
Kuehne, Martin E; He, Liwen; Jokiel, Patrick A et al. (2003) Synthesis and biological evaluation of 18-methoxycoronaridine congeners. Potential antiaddiction agents. J Med Chem 46:2716-30
Maisonneuve, Isabelle M; Glick, Stanley D (2003) Anti-addictive actions of an iboga alkaloid congener: a novel mechanism for a novel treatment. Pharmacol Biochem Behav 75:607-18
Steinmiller, Caren L; Maisonneuve, Isabelle M; Glick, Stanley D (2003) Effects of dextromethorphan on dopamine release in the nucleus accumbens: Interactions with morphine. Pharmacol Biochem Behav 74:803-10
Shoblock, James R; Sullivan, Eric B; Maisonneuve, Isabelle M et al. (2003) Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats. Psychopharmacology (Berl) 165:359-69
Glick, Stanley D; Maisonneuve, Isabelle M; Kitchen, Barbara A et al. (2002) Antagonism of alpha 3 beta 4 nicotinic receptors as a strategy to reduce opioid and stimulant self-administration. Eur J Pharmacol 438:99-105
Zhang, Wenjiang; Ramamoorthy, Yamini; Tyndale, Rachel F et al. (2002) Metabolism of 18-methoxycoronaridine, an ibogaine analog, to 18-hydroxycoronaridine by genetically variable CYP2C19. Drug Metab Dispos 30:663-9

Showing the most recent 10 out of 97 publications